About PBi

About company

PBimmunomics’ ambition is to advance methods for detecting disease early and treating affected patients with precision. We developed the Episcan platform to provide researchers with unique antibody binding profiles specific for individuals and diseases. Antibody binding profiles deliver the essential data to drive breakthroughs in disease diagnostics and treatments and develop clinical tests similar to your everyday pregnancy test. Additionally, our research team is applying Episcan to develop clinical point of care tests for Type 2 diabetes, cardiovascular disease, cancers, and other autoimmune diseases. PBimmunomics’ revolutionary Episcan platform enables precision medicine to be cost-effective and easy to apply.